Evangelos Terpos to Molecular Targeted Therapy
This is a "connection" page, showing publications Evangelos Terpos has written about Molecular Targeted Therapy.
Connection Strength
0.024
-
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA). Haematologica. 2018 09; 103(9):1422-1432.
Score: 0.024